The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer

Background: Colorectal cancer is one of the most common cancers worldwide and has a high mortality rate following disease recurrence. Treatment efficacy is maximized by providing tailored cancer treatment, ideally involving surgical resection and personalized neoadjuvant and adjuvant therapies, incl...

Full description

Bibliographic Details
Main Authors: Mifanwy Reece, Hariti Saluja, Paul Hollington, Christos S. Karapetis, Sina Vatandoust, Graeme P. Young, Erin L. Symonds
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Genetics
Subjects:
circulating tumor DNA (ctDNA)
colorectal cancer (CRC)
mutation
methylation
surgery
chemotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2019.01118/full

Internet

https://www.frontiersin.org/article/10.3389/fgene.2019.01118/full

Similar Items